113 related articles for article (PubMed ID: 17243159)
21. Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma.
Kubota M; Suita S; Tajiri T; Shono K; Fujii Y
J Pediatr Surg; 2000 Jan; 35(1):92-5. PubMed ID: 10646782
[TBL] [Abstract][Full Text] [Related]
22. Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation.
Suehiro Y; Okada T; Okada T; Anno K; Okayama N; Ueno K; Hiura M; Nakamura M; Kondo T; Oga A; Kawauchi S; Hirabayashi K; Numa F; Ito T; Saito T; Sasaki K; Hinoda Y
Clin Cancer Res; 2008 Jun; 14(11):3354-61. PubMed ID: 18519763
[TBL] [Abstract][Full Text] [Related]
23. Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma.
Shimada A; Hirato J; Kuroiwa M; Kikuchi A; Hanada R; Wakai K; Hayashi Y
Pediatr Blood Cancer; 2008 Feb; 50(2):213-7. PubMed ID: 17941064
[TBL] [Abstract][Full Text] [Related]
24. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
25. Genetic heterogeneity and ploidy level analysis among different gynogenetic clones of the polyploid gibel carp.
Wei WH; Zhang J; Zhang YB; Zhou L; Gui JF
Cytometry A; 2003 Nov; 56(1):46-52. PubMed ID: 14566938
[TBL] [Abstract][Full Text] [Related]
26. DNA content heterogeneity in neuroblastoma analyzed by means of image cytometry and its potential significance.
Melegh Z; Csernák E; Tóth E; Veleczki Z; Magyarosy E; Nagy K; Szentirmay Z
Virchows Arch; 2005 May; 446(5):517-24. PubMed ID: 15827757
[TBL] [Abstract][Full Text] [Related]
27. Single nucleotide polymorphism array analysis to predict clinical outcome in neuroblastoma patients.
Hiyama E; Yamaoka H; Kamimatsuse A; Onitake Y; Hiyama K; Nishiyama M; Sueda T
J Pediatr Surg; 2006 Dec; 41(12):2032-6. PubMed ID: 17161199
[TBL] [Abstract][Full Text] [Related]
28. [Utilization of MLPA to detection of genetic changes in neuroblastoma].
Vícha A; Eckschlager T
Klin Onkol; 2008; 21(4):149-53. PubMed ID: 19102220
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow.
Okcu MF; Wang RY; Bueso-Ramos C; Schober W; Weidner D; Andrassy R; Blakely M; Russell H; Ozkan A; Kuttesch J; Andreeff M; Chan KW; Ater J
Pediatr Blood Cancer; 2005 Nov; 45(6):787-95. PubMed ID: 15929127
[TBL] [Abstract][Full Text] [Related]
30. Differences in current clinical features of diploid and triploid hydatidiform mole.
Niemann I; Petersen LK; Hansen ES; Sunde L
BJOG; 2007 Oct; 114(10):1273-7. PubMed ID: 17655732
[TBL] [Abstract][Full Text] [Related]
31. Correlation between DNA ploidy by flow cytometry and chromosome 3 aberration in oral squamous cell carcinoma.
Hemmer J; Kraft K; Van Heerden WF
Oncol Rep; 2006 Jan; 15(1):243-6. PubMed ID: 16328063
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in childhood rhabdomyosarcoma.
San Miguel-Fraile P; Carrillo-Gijón R; Rodriguez-Peralto JL; Badiola IA
Am J Clin Pathol; 2004 Mar; 121(3):358-65. PubMed ID: 15023040
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy.
Graesslin O; Chantot-Bastaraud S; Lorenzato M; Birembaut P; Quéreux C; Daraï E
Ann Surg Oncol; 2008 Feb; 15(2):484-92. PubMed ID: 18071824
[TBL] [Abstract][Full Text] [Related]
34. DNA content in malignant salivary gland tumours.
Monteiro LS; Palmeira C; Bento MJ; Lopes C
Oral Dis; 2009 May; 15(4):295-301. PubMed ID: 19320959
[TBL] [Abstract][Full Text] [Related]
35. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
[TBL] [Abstract][Full Text] [Related]
36. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.
Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H
Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816
[TBL] [Abstract][Full Text] [Related]
38. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z
Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928
[TBL] [Abstract][Full Text] [Related]
39. Hypoploidy defines patients with poor prognosis in breast cancer.
Chavez-Uribe E; Cameselle-Teijeiro J; Viñuela JE; Castro-Piñeiro C; Gude F; Forteza J; Puente-Domínguez JL
Oncol Rep; 2007 May; 17(5):1109-14. PubMed ID: 17390052
[TBL] [Abstract][Full Text] [Related]
40. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.
Sander S; Bullinger L; Leupolt E; Benner A; Kienle D; Katzenberger T; Kalla J; Ott G; Müller-Hermelink HK; Barth TF; Möller P; Lichter P; Döhner H; Stilgenbauer S
Haematologica; 2008 May; 93(5):680-7. PubMed ID: 18367489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]